Sören Lehmann group - Acute myeloid leukemia

Our group is focused on translational research of acute myeloid leukemia, the most common acute leukemia in adults. The aim is to improve the understanding of disease biology as well as to improve outcome for AML patients.

Our studies include basic molecular characterization of AML versus normal hematopoeisis with a focus on epigenetic dysregulation and its relation to genetic events and prognosis. Furthermore, we are leading clinical studies with experimental antileukemic treatment strategies including targeting dysregulation of the p53 pathway as well as of the epigenetic machinery.

We work in close collaboration with other groups at Karolinska Institutet, the Swedish AML group and international collaborators.

Group leader

Soren Lehmann

Group leader
H7 Department of Medicine, Huddinge

Group members

Stefan Deneberg

Affiliated to research
H7 Department of Medicine, Huddinge

Sofia Bengtzén

Affiliated to research
H7 Department of Medicine, Huddinge

Christer Paul

Affiliated to research
H7 Department of Medicine, Huddinge

Christer Nilsson

Affiliated to research
H7 Department of Medicine, Huddinge